UNSPSC 51343301: Xenazoic acid

This classification denotes an antiviral agent with the molecular formula C23H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KDU8VH09O8, chemically known as benzoic acid, p-(alpha-ethoxy-p-phenylphenacylamino)- but generally known as xenazoic acid, which bears US NIH Compound Identifier 239062. European Medicines Agency schedules Xenazoic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00101MIG.

UNSPSC 51343301 Xenazoic acid is a Commodity code that does not show relevant recent state and local procurement activity. The four opportunities posted between January and July 2026 address naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS Commission), emergency medical and first aid supplies (City of Tampa Fire Department), and generic pharmaceuticals and OTC products through cooperative purchasing (Minnesota MMCAP)—none of which involve xenazoic acid or closely related pharmaceutical actives under this code's nominal scope. The mismatch between the code classification and the actual goods being solicited suggests either miscategorization in the source data or that xenazoic acid procurement does not currently draw state and local buyer interest at scale sufficient to populate this code with relevant opportunities.

Absent substantive recent activity under this code, the issuing-body and geographic signals are not actionable. The opportunities that do appear span state health agencies (Texas HHS Commission, Minnesota Department of Administration), county health departments (Seminole County), municipal fire departments (City of Tampa), and multistate cooperative purchasing vehicles (MMCAP serving Minnesota and Oregon members), but none relate to the Commodity code in question. A firm evaluating this code should monitor whether future pharmaceutical procurement activity—particularly for specialty actives or niche health-department purchases—begins to accumulate under UNSPSC 51343301 rather than route through higher-tier pharmaceutical or OTC product codes.